News coverage about Cotiviti (NYSE:COTV) has trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cotiviti earned a daily sentiment score of 0.20 on Accern’s scale. Accern also gave news coverage about the business services provider an impact score of 45.6196216329769 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Shares of COTV stock opened at $44.74 on Friday. Cotiviti has a 12-month low of $30.84 and a 12-month high of $44.76. The company has a market capitalization of $4.20 billion, a P/E ratio of 31.51, a price-to-earnings-growth ratio of 2.10 and a beta of 0.52. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.41 and a quick ratio of 3.41.

Cotiviti (NYSE:COTV) last issued its quarterly earnings data on Thursday, July 26th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Cotiviti had a return on equity of 12.44% and a net margin of 21.49%. The business had revenue of $176.85 million during the quarter, compared to analyst estimates of $183.38 million. During the same period in the prior year, the company posted $0.38 EPS. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. equities research analysts forecast that Cotiviti will post 1.67 EPS for the current fiscal year.

A number of brokerages have recently weighed in on COTV. Zacks Investment Research upgraded Cotiviti from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 21st. Citigroup cut Cotiviti from a “buy” rating to a “neutral” rating and set a $29.00 price target on the stock. in a research report on Wednesday, July 18th. Leerink Swann cut Cotiviti from an “outperform” rating to a “market perform” rating and set a $48.00 price target on the stock. in a research report on Tuesday, July 3rd. Credit Suisse Group cut Cotiviti from an “outperform” rating to a “neutral” rating and dropped their price target for the stock from $46.00 to $44.75 in a research report on Thursday, June 21st. Finally, SunTrust Banks cut Cotiviti from a “buy” rating to a “hold” rating and set a $24.00 price target on the stock. in a research report on Tuesday, June 19th. One analyst has rated the stock with a sell rating and twelve have issued a hold rating to the company. Cotiviti has an average rating of “Hold” and a consensus target price of $36.07.

In related news, COO David Beaulieu sold 5,000 shares of the stock in a transaction that occurred on Friday, June 15th. The stock was sold at an average price of $39.80, for a total value of $199,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jonathan Olefson sold 20,000 shares of the stock in a transaction that occurred on Tuesday, June 19th. The stock was sold at an average price of $41.10, for a total value of $822,000.00. Following the completion of the transaction, the senior vice president now directly owns 20,884 shares of the company’s stock, valued at $858,332.40. The disclosure for this sale can be found here. Insiders sold a total of 30,000 shares of company stock valued at $1,243,050 over the last three months. Corporate insiders own 7.50% of the company’s stock.

About Cotiviti

Cotiviti Holdings, Inc, through its subsidiaries, provides analytics-driven payment accuracy and spend management solutions primarily for the healthcare sector in the United States, Canada, the United Kingdom, and India. It operates through two segments, Healthcare, and Global Retail and Other. The company offers prospective claims accuracy solutions that enable healthcare clients identify and address claim discrepancies immediately following claim adjudication and before a claim is paid to a healthcare provider; and retrospective claims accuracy solutions that enable health insurers identify and resolve payment inaccuracies after a claim has been paid to a healthcare provider.

Read More: Trading Strategy Examples and Plans

Insider Buying and Selling by Quarter for Cotiviti (NYSE:COTV)

Receive News & Ratings for Cotiviti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti and related companies with MarketBeat.com's FREE daily email newsletter.